Product: CABOPROST 250 mcg/mL Injection

Brand Name: CABOPROST 250 mcg/mL
Content: Carboprost Tromethamine Injection I.P. – a sterile oxytocic/uterotonic solution.
Company / Manufacturer: Neon Lab Ltd / Neon Laboratories Ltd – Indian pharmaceutical company.
Pack: 1 mL ampoule containing 250 mcg carboprost tromethamine.

CABOPROST 250 mcg/mL Injection is a prescription injectable medicine containing Carboprost Tromethamine, a synthetic analogue of prostaglandin F2α with strong uterotonic (uterus‑contracting) activity. It is used in hospital and clinical settings under medical supervision to assist with obstetric and gynecological management where increased uterine muscle contraction is required.

�� Key Features

·         Active Ingredient: Carboprost Tromethamine I.P. (250 mcg per mL).

·         Dosage Form: Sterile injectable solution in a single‑dose ampoule.

·         Administration: Given intramuscularly (IM) by a healthcare professional in a hospital or clinic.

·         Prescription: Required – to be used only under clinician supervision.

�� Therapeutic Uses

CARBOPROST TROMETHAMINE Injection is primarily used for:

·         Controlling severe postpartum hemorrhage (excessive bleeding) after childbirth due to uterine atony.

·         Termination of pregnancy (medical abortion) in the second trimester (13–20 weeks) where other methods are insufficient or not appropriate.

·         Management of incomplete abortion by promoting uterine contractions.

It works by stimulating contraction of the uterine smooth muscle, facilitating hemostasis (stoppage of bleeding) and evacuation of the uterus.

⚠️ Important Notes & Safety

·         Administered Only by Medical Professionals: Should be given IM in a hospital with appropriate monitoring and resuscitation facilities.

·         Side Effects: May include nausea, vomiting, diarrhea, flushing, headache, fever/chills, abdominal cramps, and increased uterine contractions.

·         Precautions: Contraindicated or used with caution in patients with active cardiac, pulmonary, renal, or hepatic disease, and in those with known hypersensitivity to prostaglandins.

·         Storage: Typically stored in a refrigerator (2–8 °C) and protected from light; do not freeze.

·         Not for Self‑Administration: To be used only in clinical settings under supervision.

�� Category :- Obstetric / Gynecological Injectable – Uterotonic / Oxytocic Agent